Cancer Monoclonal Antibodies Market To 2015
RNCOS has recently added a new Market Research Report titled
, Cancer Monoclonal Antibodies Market to 2015 to its report gallery. Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In order to treat the life-threatening disease more efficiently and with enhanced specificity, monoclonal antibodies have become the most widely used cancer therapy. As per the findings of our new research report, cancer monoclonal antibodies provide high specificity to treat tumors and several formats exist for the types of cancer monoclonal antibodies available.
According to Cancer Monoclonal Antibodies Market to 2015, cancer monoclonal antibodies have evolved greatly from the first time they were implemented, and have created a strong demand since then. In the recent time, some very important monoclonal antibodies, such as Yervoy (ipilimumab) have entered the market. Our study expects that these antibodies will consume the share of leading monoclonal antibody products in the coming years.
Our research observed that the strong demand for effective cancer treatments and high prevalence are driving the cancer monoclonal antibodies market which is anticipated to grow at a CAGR of around 7% during 2012-2015. While research and innovation in this field have been growing exorbitantly, the industry has witnessed a large number of consolidation activities. In the report, we have also studied how technological advancements and a subsequent increase in number of approvals are influencing the market growth.
During the study of latest industry trends and drivers, we observed that conjugated cancer antibody therapies offer efficient cancer treatments. Besides, bispecific antibodies (BiAbs) present a unique opportunity to redirect immune effector cells to kill cancer cells. Our report covers the analysis of the entire monoclonal antibody market for cancer, and presents market forecasts for leading products. The geographic analyses for key markets, carried out in the research, foresee that the US and Europe will continue holding significant market shares, and
Japan will exhibit unaltered double digit growth.
In our research report, we have conducted a comprehensive pipeline analysis of the expected cancer monoclonal antibodies and their phase of development. We found that maximum products are expected in the field of breast cancer in near future. The study discusses in detail the key market players, their business activities, key monoclonal antibody products which are available in the market and in pipeline. Overall, we expect the cancer monoclonal antibody market to show stupendous growth and great evolution in the coming years.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM375.htm
Some of our Related Reports are:
- Interferon Market Forecast to 2015 (http://www.rncos.com/Report/IM431.htm)
- Insulin Market Forecast to 2015 (http://www.rncos.com/Report/IM430.htm)
- Human Growth Hormone Market Forecast to 2015 (http://www.rncos.com/Report/IM429.htm)
- Erythropoietin Market Forecast to 2015 (http://www.rncos.com/Report/IM428.htm)
- Global Biotech API Market Analysis (http://www.rncos.com/Report/IM424.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
by: Shushmul Maheshwari
Gastric Cancer Diagnosis Types Of Gastric Cancer Quick Look Into Stages Of Gastric Cancer Treatment Of Gastric Cancer Invisalign Dallas Treatments Causes Of Gastric Cancer Stages Of Heart Cancer Diagnosis Of Heart Cancer Primary Heart Cancer Heart Cancer What Are The Best Treatments To Minimize Cellulite? Lifestyle Changes could Prevent Half Of All Cancers Gemini 2013, Cancer 2013, Libra 2013, Virgo 2013, Taurus 2013 - 2013 Predictions